Christi Murphy

Christi Murphy is an accomplished Key Account Manager at CTI BioPharma, specializing in the launch of Vonjo, a medication for myelofibrosis, since October 2021. Prior to this role, Christi served as an Oncology Account Manager at Jazz Pharmaceuticals, promoting Zepzelca and Vyxeos, and worked at Merck as an Oncology Specialty Representative, focusing on Keytruda and Lemvima. Experience at Sanofi Genzyme involved launching an anti-PD1 treatment for rare cancers, achieving a significant sales growth of 15%. Christi's career includes a Therapeutic Specialist role at Gilead Sciences, launching innovative Hepatitis C treatments, and an Immunology Sales Specialist position at Abbott. A Clinical Specialist at Genentech, Christi was instrumental in launching Xolair™, significantly impacting asthma management. The career began at Schering Plough as a Pharmaceutical Representative, selling cardiovascular and respiratory medications. Christi holds a BS in Marketing from Minnesota State University Moorhead.